Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types
- PMID: 1685995
- DOI: 10.1016/0014-2999(91)90590-m
Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types
Abstract
Triglyceride mobilization and adenylyl cyclase activation in adipocytes from Wistar rats, lean Zucker (Fa/?) rats, obese Zucker (fa/fa) rats and humans were investigated in concentration-response studies with (-)-isoprenaline and the atypical beta 3-adrenoceptor selective agonist BRL 37344. Maximum FFA production by both agonists was identical in Wistar rat and lean Zucker rat adipocytes, while obese Zucker rat adipocytes and human adipocytes produced significantly less FFA, especially with BRL 37344. Maximum adenylyl cyclase activation by (-)-isoprenaline was similar for all types of adipocyte ghosts, whereas BRL 37344 was a partial agonist in all cases with the lowest intrinsic activity in human adipocytes. For (-)-isoprenaline the relationship between cAMP and lipolysis was steepest with Wistar rat adipocytes, followed by human and lean Zucker rat adipocytes, while obese Zucker rat cells showed a shallow relationship. For BRL 37344, the relationship was very steep and similar for all four adipocyte types, despite the marked differences in maximal lipolysis and cyclic AMP production. The results strongly argue in favour of cyclic AMP compartmentalization, the activity ratio between the functional and the non-functional compartment being least favourable in obese Zucker rat adipocytes. The atypical beta 3-adrenoceptor agonist BRL 37344 very efficiently directs the generated cyclic AMP into the functional compartment in all four adipocytes types investigated.
Similar articles
-
Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes.Br J Pharmacol. 1991 Mar;102(3):577-80. doi: 10.1111/j.1476-5381.1991.tb12215.x. Br J Pharmacol. 1991. PMID: 1364822 Free PMC article.
-
Discrepancies in lipolytic activities induced by beta-adrenoceptor agonists in human and rat adipocytes.Horm Metab Res. 1990 Jan;22(1):17-21. doi: 10.1055/s-2007-1004839. Horm Metab Res. 1990. PMID: 1968415
-
Correlation of beta 3-adrenoceptor-induced activation of cyclic AMP-dependent protein kinase with activation of lipolysis in rat white adipocytes.Biochem Pharmacol. 1993 Aug 17;46(4):575-81. doi: 10.1016/0006-2952(93)90540-d. Biochem Pharmacol. 1993. PMID: 8103324
-
Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein.Prostaglandins Leukot Essent Fatty Acids. 1993 Jan;48(1):105-9. doi: 10.1016/0952-3278(93)90017-q. Prostaglandins Leukot Essent Fatty Acids. 1993. PMID: 8380931 Review.
-
Adipocyte hormone responsiveness and aging in the rat: problems in the interpretation of aging research.J Am Geriatr Soc. 1984 Mar;32(3):219-28. doi: 10.1111/j.1532-5415.1984.tb02006.x. J Am Geriatr Soc. 1984. PMID: 6321584 Review.
Cited by
-
Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?Biomolecules. 2023 Nov 28;13(12):1714. doi: 10.3390/biom13121714. Biomolecules. 2023. PMID: 38136585 Free PMC article. Review.
-
Evidence for a functional beta 3-adrenoceptor in man.Br J Pharmacol. 1993 Nov;110(3):929-36. doi: 10.1111/j.1476-5381.1993.tb13902.x. Br J Pharmacol. 1993. PMID: 7905344 Free PMC article.
-
Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.Pharmacol Res. 2019 Aug;146:104293. doi: 10.1016/j.phrs.2019.104293. Epub 2019 Jun 6. Pharmacol Res. 2019. PMID: 31176794 Free PMC article. Review.
-
Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.Br J Pharmacol. 1996 Mar;117(6):1355-61. doi: 10.1111/j.1476-5381.1996.tb16736.x. Br J Pharmacol. 1996. PMID: 8882636 Free PMC article.
-
Demonstration of an in vivo functional beta 3-adrenoceptor in man.J Clin Invest. 1995 May;95(5):2239-45. doi: 10.1172/JCI117914. J Clin Invest. 1995. PMID: 7738189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources